Contrast Induced Nephropathy - Pipeline Review, H1 2019

Publisher Name :
Date: 21-May-2019
No. of pages: 45
Inquire Before Buying

Contrast Induced Nephropathy - Pipeline Review, H1 2019

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Contrast Induced Nephropathy - Pipeline Review, H1 2019, provides an overview of the Contrast Induced Nephropathy (Genito Urinary System And Sex Hormones) pipeline landscape.

Contrast-induced nephropathy (CIN) is defined as the impairment of renal function (measured as either a 25%increase in serum creatinine (SCr) from baseline or a 0.5 mg/dL (44 ?mol/L) increase in absolute SCr value after 48-72 hrs contrast administration). Symptoms include feeling more tired, poor appetite, swelling in the feet and ankles,puffiness around the eyes, or dry and itchy skin. Risk factors include age, diabetes, decreased kidney function and congestive heart failure. Treatment includes electrolyte management.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Contrast Induced Nephropathy - Pipeline Review, H1 2019, provides comprehensive information on the therapeutics under development for Contrast Induced Nephropathy (Genito Urinary System And Sex Hormones), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Contrast Induced Nephropathy (Genito Urinary System And Sex Hormones) pipeline guide also reviews of key players involved in therapeutic development for Contrast Induced Nephropathy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase II, Preclinical and Discovery stages are 3, 3 and 1 respectively.

Contrast Induced Nephropathy (Genito Urinary System And Sex Hormones) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Contrast Induced Nephropathy (Genito Urinary System And Sex Hormones).

- The pipeline guide reviews pipeline therapeutics for Contrast Induced Nephropathy (Genito Urinary System And Sex Hormones) by companies and universities/research institutes based on information derived from company and industry-specific sources.

- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.

- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

- The pipeline guide reviews key companies involved in Contrast Induced Nephropathy (Genito Urinary System And Sex Hormones) therapeutics and enlists all their major and minor projects.

- The pipeline guide evaluates Contrast Induced Nephropathy (Genito Urinary System And Sex Hormones) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.

- The pipeline guide reviews latest news related to pipeline therapeutics for Contrast Induced Nephropathy (Genito Urinary System And Sex Hormones)

Reasons to buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.

- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.

- Find and recognize significant and varied types of therapeutics under development for Contrast Induced Nephropathy (Genito Urinary System And Sex Hormones).

- Classify potential new clients or partners in the target demographic.

- Develop tactical initiatives by understanding the focus areas of leading companies.

- Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.

- Formulate corrective measures for pipeline projects by understanding Contrast Induced Nephropathy (Genito Urinary System And Sex Hormones) pipeline depth and focus of Indication therapeutics.

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.

- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Contrast Induced Nephropathy - Pipeline Review, H1 2019

Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Contrast Induced Nephropathy - Overview
Contrast Induced Nephropathy - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Products under Development by Companies
Contrast Induced Nephropathy - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Contrast Induced Nephropathy - Companies Involved in Therapeutics Development
Daiichi Sankyo Co Ltd
Pharming Group NV
Radikal Therapeutics Inc
Contrast Induced Nephropathy - Drug Profiles
C1 esterase inhibitor (recombinant) - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
carperitide - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
R-100 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
R-801 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
R-901 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
R-911 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ST-62516 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Contrast Induced Nephropathy - Dormant Projects
Contrast Induced Nephropathy - Discontinued Products
Contrast Induced Nephropathy - Product Development Milestones
Featured News & Press Releases
Oct 17, 2018: Pharming reports positive data from first investigator-initiated study of rhC1-Inhibitor (RUCONEST) in Contrast-induced Nephropathy
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Number of Products under Development for Contrast Induced Nephropathy, H1 2019
Number of Products under Development by Companies, H1 2019
Products under Development by Companies, H1 2019
Number of Products by Stage and Target, H1 2019
Number of Products by Stage and Mechanism of Action, H1 2019
Number of Products by Stage and Route of Administration, H1 2019
Number of Products by Stage and Molecule Type, H1 2019
Contrast Induced Nephropathy - Pipeline by Daiichi Sankyo Co Ltd, H1 2019
Contrast Induced Nephropathy - Pipeline by Pharming Group NV, H1 2019
Contrast Induced Nephropathy - Pipeline by Radikal Therapeutics Inc, H1 2019
Contrast Induced Nephropathy - Dormant Projects, H1 2019
Contrast Induced Nephropathy - Discontinued Products, H1 2019

List of Figures
Number of Products under Development for Contrast Induced Nephropathy, H1 2019
Number of Products under Development by Companies, H1 2019
Number of Products by Targets, H1 2019
Number of Products by Stage and Targets, H1 2019
Number of Products by Top 10 Mechanism of Actions, H1 2019
Number of Products by Stage and Mechanism of Actions, H1 2019
Number of Products by Top 10 Routes of Administration, H1 2019
Number of Products by Stage and Top 10 Routes of Administration, H1 2019
Number of Products by Molecule Types, H1 2019
Number of Products by Stage and Molecule Types, H1 2019
  • Global Dental Silica Market Professional Survey 2019 by Manufacturers, Regions, Countries, Types and Applications, Forecast to 2024
    Published: 19-Jul-2019        Price: US 2900 Onwards        Pages: 193
    The Dental Silica market was valued at XX Million US$ in 2018 and is projected to reach XX Million US$ by 2024, at a CAGR of XX% during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2024 as the forecast period to estimate the market size for Dental Silica. Global Dental Silica industry market professional research 2014-2024, is a report which provides the details about industry overview, industry chain, market size (sales, revenue, and g......
  • Global Eye Allergy Therapeutics Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 19-Jul-2019        Price: US 3480 Onwards        Pages: 118
    All types of eye allergies are associated with chronic symptoms such as ocular itching inflammation redness and watery eyes, which are persistently disturbing, having an adverse effect on patients' life. Scope of the Report: The worldwide market for Eye Allergy Therapeutics is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focu......
  • Global Radiodermatitis Treatment Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 19-Jul-2019        Price: US 3480 Onwards        Pages: 119
    Radiodermatitis is the integumentary system's response to exposure to ionizing radiation. Scope of the Report: The worldwide market for Radiodermatitis Treatment is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Radiodermatitis Treatment in global market, especially in North America, Europe and Asia-Pacific, Sou......
  • Global Staphylococcal Infection Drugs Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 19-Jul-2019        Price: US 3480 Onwards        Pages: 124
    Staphylococcal infections are usually caused by the organism Staphylococcus aureus. Scope of the Report: The worldwide market for Staphylococcal Infection Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Staphylococcal Infection Drugs in global market, especially in North America, Europe and Asia-Pacific, ......
  • Global Equine Supplement Products Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 19-Jul-2019        Price: US 3480 Onwards        Pages: 124
    Equine supplement products market is driven by rise in demand for herbal equine supplements, increase in incidence of equine diseases, and surge in government initiatives toward equine health. Scope of the Report: The worldwide market for Equine Supplement Products is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on th......
  • Global Postoperative Pain Therapeutics Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 19-Jul-2019        Price: US 3480 Onwards        Pages: 120
    As the global healthcare space is seeing a palpable shift toward a 'value-based care' model, postoperative pain management is gaining its very own eminence. Scope of the Report: The worldwide market for Postoperative Pain Therapeutics is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Postoperative Pain Therapeuti......
  • 2019-2023 Global Thrombin Time Market: US, Europe, Japan--Volume and Sales Segmentation Forecasts, Competitive Landscape, Current Methods and Instrumentation, Opportunities for Suppliers
    Published: 18-Jul-2019        Price: US 3450 Onwards        Pages: 196
    The growing cost-containment pressures in major industrialized nations and continued technological advances will radically change coagulation testing practice during the next five years. New specific and sensitive markers of hemostasis will be increasingly used on automated instrumentation. Coagulation testing in general, and Thrombin Time testing specifically, will become more standardized, offering opportunities for quality control products and services. Moreover, the continuing contraction......
  • Benzyl trimethyl ammonium bromide (CAS 56-93-9) Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    Published: 18-Jul-2019        Price: US 3000 Onwards        Pages: 143
    Benzyl trimethyl ammonium bromide Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Benzyl trimethyl ammonium bromide industry with a focus on the Chinese market. The report provides key statistics on the market status of the Benzyl trimethyl ammonium bromide manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Overall, the report provides an in-depth insi......
  • Benzyl triethyl ammonium bromide (CAS 56-37-1) Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    Published: 18-Jul-2019        Price: US 3000 Onwards        Pages: 148
    Benzyl triethyl ammonium bromide Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Benzyl triethyl ammonium bromide industry with a focus on the Chinese market. The report provides key statistics on the market status of the Benzyl triethyl ammonium bromide manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Overall, the report provides an in-depth insight......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs